These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3023256)

  • 1. Enalapril: a new angiotensin-converting enzyme inhibitor.
    McRaith J; Fitz A
    Iowa Med; 1986 Oct; 76(10):482, 484, 486-8. PubMed ID: 3023256
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical pharmacology of enalapril.
    Gomez HJ; Cirillo VJ; Jones KH
    J Hypertens Suppl; 1983 Oct; 1(1):65-70. PubMed ID: 6100610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enalapril: a new angiotensin converting enzyme inhibitor.
    Cleary JD; Taylor JW
    Drug Intell Clin Pharm; 1986 Mar; 20(3):177-86. PubMed ID: 3007062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of enalapril. Summing up the evidence.
    Dollery CT
    J Hypertens Suppl; 1983 Oct; 1(1):155-7. PubMed ID: 6100605
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new angiotensin-converting enzyme inhibitor is imminent].
    Michel D
    Fortschr Med; 1988 Jul; 106(22):463-6. PubMed ID: 2851512
    [No Abstract]   [Full Text] [Related]  

  • 6. Lisinopril: a new ACE inhibitor for the treatment of hypertension and congestive heart failure.
    Chodoff L
    Mt Sinai J Med; 1990 May; 57(3):169-71. PubMed ID: 2164644
    [No Abstract]   [Full Text] [Related]  

  • 7. Lisinopril--another ACE inhibitor.
    Drug Ther Bull; 1989 Apr; 27(8):31-2. PubMed ID: 2562398
    [No Abstract]   [Full Text] [Related]  

  • 8. [Enalapril--an oral angiotensin-converting enzyme inhibitor: its pharmacological properties and clinical use].
    Wiecek A; Grzeszczak W
    Pol Tyg Lek; 1988 Feb; 43(9):279-83. PubMed ID: 2841654
    [No Abstract]   [Full Text] [Related]  

  • 9. Lisinopril for hypertension.
    Med Lett Drugs Ther; 1988 Apr; 30(763):41-2. PubMed ID: 2832713
    [No Abstract]   [Full Text] [Related]  

  • 10. A new angiotensin-converting enzyme inhibitor: treatment of hypertension and congestive heart failure. Proceedings of an international symposium on enalapril, sponsored by Merck Sharp & Dohme International, São Paulo, Brazil, November 10, 1984.
    Drugs; 1985; 30 Suppl 1():1-96. PubMed ID: 2994983
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical pharmacology of the angiotensin converting enzyme inhibitor, enalapril.
    Brunner HR; Nussberger J; Waeber B
    Acta Cardiol; 1986; 41(5):341-50. PubMed ID: 3022510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renpress, Sandopril (Spirapril/TI 211-950). Summary of chemical, pharmacological and clinical properties.
    Jerie P; Kremer HJ
    Cor Vasa; 1992; 34(1):82-7. PubMed ID: 1288944
    [No Abstract]   [Full Text] [Related]  

  • 13. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
    Adewole AD; Ikem RT; Adigun AQ; Akintomide AO; Balogun MO; Ajayi AA
    Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Captopril and enalapril: angiotensin converting enzyme (ACE) inhibitors.
    Ferguson RK; Vlasses PH; Riley LJ
    Ration Drug Ther; 1984 Mar; 18(3):1-5. PubMed ID: 6093192
    [No Abstract]   [Full Text] [Related]  

  • 16. Captopril and enalapril: angiotensin-converting enzyme inhibitors.
    Allen TA; Wilke WL; Fettman MJ
    J Am Vet Med Assoc; 1987 Jan; 190(1):94-6. PubMed ID: 3028998
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
    Davie AP; Rumley A; Lowe GD; McMurray JJ
    Thromb Haemost; 2001 Dec; 86(6):1585-6. PubMed ID: 11776334
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of subchronic treatment with trandolapril and enalapril on cardiovascular morphologic alterations in the aged spontaneously hypertensive rat with heart failure.
    Secchi J; Lecaque D; Dunn FW; Jouquey S; Auberval UD; Benzoni F; Sirugue O; Hamon G
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S30-7. PubMed ID: 7527099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical pharmacology of enalapril].
    Giudicelli JF
    Presse Med; 1985 Dec; 14(44):2209-11. PubMed ID: 3003727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.